Biotechnology
News Category
VivoSim Labs Secures $4 Million Private Placement from Healthcare Investor
VivoSim Labs announced a $4 million private placement with a healthcare-focused institutional investor, issuing shares and warrants at $0.85 per share...
Greenwich LifeSciences Advances Phase 3 Trial for Breast Cancer Immunotherapy
Greenwich LifeSciences reports DSB approval to continue Phase 3 FLAMINGO-01 trial for GLSI-100, with expanded enrollment and preliminary data showing ...
Quantum BioPharma Develops Two-Pronged Attack on Brain Disorders Affecting Millions
Quantum BioPharma is advancing a pipeline targeting multiple sclerosis and alcohol intoxication, with Lucid-MS for MS and unbuzzd for hangover relief,...
American Fusion Inc. Secures Texas Certificate of Registration for Fusion Engine Testing at Texas Tech University
American Fusion Inc. received a Texas DSHS certificate allowing research and development of its Texatron Fusion Engine systems, advancing its fusion e...
WHO Study Finds No Evidence That Mobile Phones Cause Brain Cancer
A comprehensive review commissioned by the World Health Organization found no link between mobile phone use and brain cancer, alleviating long-standin...
Quantum BioPharma Achieves Key Enrollment Milestone in MS Imaging Study, Early Data Shows Promise
Quantum BioPharma's imaging study for multiple sclerosis reaches halfway enrollment, with preliminary data showing a meaningful signal in MS lesions, ...
GeoVax Highlights Strategic Alignment of GEO-MVA With HHS/ASPR's Five-Year Medical Countermeasure Preparedness Strategy
GeoVax's GEO-MVA vaccine platform aligns with the HHS/ASPR's five-year strategy emphasizing domestic manufacturing, platform technologies, and pandemi...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its BiTAC-TCE cancer therapy program, providing clarity...
VERAXA Biotech Receives Positive Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech announced Scientific Advice from Germany's Paul-Ehrlich-Institute, validating its dual-targeting BiTAC-TCE platform and supporting its ...
Regentis Biomaterials Secures Japan Patent Allowance for GelrinC Manufacturing Technology
Regentis Biomaterials Ltd. received a Japan patent allowance for its organic solvent-free manufacturing process for GelrinC, a regenerative knee carti...
MindBio Therapeutics Advances Voice-Based AI Tech for Real-Time Impairment Detection
MindBio Therapeutics is developing an AI-powered voice analysis platform to detect drug and alcohol impairment in real time, targeting workplace safet...
Study Links Gut Microbial Metabolites to Enhanced Cancer Immunotherapy Sensitivity
A new study finds that metabolites from gut bacteria can improve responses to cancer immunotherapy, offering insights into why some patients benefit m...
SS Innovations Appoints Sarah M. Romano as CFO Amid Global Expansion of Robotic Surgery Platform
SS Innovations International Inc. has appointed veteran medtech finance executive Sarah M. Romano as CFO to support its global expansion and FDA clear...
Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Advance POCT Diagnostics
Creative Biolabs announces a unified platform combining microfluidics and electrochemical biosensors to enable scalable, high-precision point-of-care ...
BioAdaptives Details Xcellara Platform Strategy Ahead of XcellaraHeart Launch
BioAdaptives outlines its cellular wellness platform strategy, leveraging a clinically proven stem cell mobilization base with tissue-specific ingredi...
NeuroOne Expands Drug Delivery Program Through Collaboration With Mayo Clinic on Pediatric Brain Cancer Trial
NeuroOne Medical Technologies announced a collaboration with Mayo Clinic, funded by a Children's Cancer Research Fund grant, to evaluate a novel drug ...
Oncotelic Therapeutics Launches AI-Powered GMP Manufacturing Platform
Oncotelic Therapeutics introduces an AI-driven manufacturing platform combining PDAOAI architecture with robotics to help biotech firms access full GM...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma has reported positive Phase 1 safety data for its neuroprotective therapy LUCID-MS and submitted an IND to the FDA, advancing the ca...
VERAXA Biotech Leverages AI to Accelerate Cancer Therapy Development
VERAXA Biotech's collaboration with AI firm Ardigen aims to enhance its BiTAC oncology platform through AI-enabled target discovery, potentially reduc...
Tonix Pharmaceuticals Publishes Mpox Research Supporting TNX-801 Vaccine Development
New preclinical research published in the Journal of Virology reveals that the circulating mpox virus clade IIb is up to 100,000 times less virulent t...
Nuvectis Pharma Prices $100 Million Public Offering to Advance Pipeline Programs
Nuvectis Pharma announced the pricing of a $100 million public offering to fund the development of its NXP100, NXP200, and NXP900 programs, highlighti...
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced positive interim safety results from its Phase 1 trial of ENV-105 combined with osimertinib for EGFR-mutated NSCLC, showing no...
NeuroThera Labs Initiates Phase IIb Clinical Trial at Hannover Medical School for Tourette Syndrome Treatment
NeuroThera Labs has begun its Phase IIb trial for SCI-110, a cannabinoid-based treatment for Tourette Syndrome, at Hannover Medical School, advancing ...
Earth Science Tech Inc. Leverages Technology and Strategic Positioning to Advance the Telehealth Industry
Earth Science Tech Inc. (ETST) is capitalizing on the growing telehealth and peptide therapy markets through its subsidiaries and proprietary technolo...
Formycon and OneSource Specialty Pharma Forge Strategic Biosimilar Manufacturing Partnership
Formycon AG partners with OneSource Specialty Pharma to leverage India-based manufacturing for cost-efficient, high-quality biosimilar production, aim...
Quantum BioPharma Advances LUCID-MS Toward Phase 2 Trial for Multiple Sclerosis
Quantum BioPharma Ltd. progresses its neuroprotective therapy LUCID-MS, which targets myelin restoration in multiple sclerosis, into Phase 2 clinical ...
Quantum BioPharma Advances LUCID-MS Toward Phase 2 Trials for Multiple Sclerosis
Quantum BioPharma's LUCID-MS therapy shows promise in Phase 1 trials, targeting myelin repair in multiple sclerosis, with a Phase 2 trial planned afte...
Silo Pharma Subsidiary QwikAgents Joins AMD AI Developer Program
Silo Pharma's subsidiary QwikAgents has been accepted into AMD's AI Developer Program, which will provide access to credits, tools, and resources to a...
VERAXA Biotech Leverages AI in Partnership with Ardigen to Advance BiTAC Cancer Therapy Platform
VERAXA Biotech's collaboration with AI firm Ardigen aims to accelerate target discovery for its BiTAC platform, highlighting the growing impact of art...
DN Group AG Subsidiary Algene Achieves First Microalgae Harvest, Begins Series Production
Algene Holding SE, a subsidiary of DN Group AG, has successfully completed its first harvest of high-purity microalgae, achieving 4,500 litres and ini...
VERAXA Biotech Partners With Ardigen to Advance AI-Driven Cancer Drug Development
VERAXA Biotech collaborates with Ardigen to integrate artificial intelligence into its BiTAC pipeline of T-cell engagers and antibody-drug conjugates,...
NanoViricides Gets Ethics Nod for Phase II Ebola Trial in DRC, Pivotal for Oral Treatment Access
NanoViricides received ethics approval for a Phase II trial of NV-387 oral gummies against Bundibugyo ebolavirus in the DRC, potentially offering the ...
Tonix Pharmaceuticals Expands TONMYA Medicare Coverage to 145 Million Lives
Tonix Pharmaceuticals announced a major managed Medicare agreement for TONMYA, adding approximately 9 million Medicare beneficiaries and bringing tota...
VERAXA Biotech Partners with Ardigen to Integrate AI into Cancer Drug Development
VERAXA Biotech AG has partnered with Ardigen to leverage artificial intelligence for optimizing its BiTAC pipeline of T-cell engagers, aiming to impro...
Onco-Innovations Completes Reference Standard Program for ONC010, Bolstering CMC Framework
Onco-Innovations Limited announced the successful completion of an analytical reference standard program for its lead oncology candidate ONC010, a key...
VERAXA Biotech Appoints Carl von Halem as Interim CFO Amid Permanent Search
VERAXA Biotech has appointed Carl von Halem as interim CFO to lead its finance function during a transition, leveraging his experience in corporate fi...
Novel Feeder-Free TIL Expansion Platform Reduces IL-2 Dependence, Enhances Safety and Efficacy in Preclinical Study
A new preclinical study demonstrates that a feeder-free TIL expansion protocol with low-dose IL-2 and PD-1 blockade improves safety and efficacy, pote...
New Breast Cancer Classification Based on Cancer-Immunity Cycle Could Personalize Immunotherapy
Researchers developed a framework classifying breast cancer into three subtypes based on the cancer-immunity cycle, predicting immunotherapy response ...
Greenland Mines Secures Australian Patent for Klotho Gene Therapy Platform
Greenland Mines (GRML) has been granted an Australian patent for its Klotho gene therapy platform, strengthening its intellectual property for treatin...
Quantum BioPharma Advances Diversified Pipeline Targeting Neurodegenerative and Metabolic Disorders
Quantum BioPharma (NASDAQ: QNTM) is highlighted for its diversified platform spanning clinical-stage therapeutics, consumer wellness products, and str...
Greenland Mines Secures Australian Patent for Klotho Gene Therapy Platform
Greenland Mines Ltd (NASDAQ: GRML) announced that IP Australia has granted a patent covering its Klotho gene therapy technology, strengthening its int...
VERAXA Biotech Advances Lead BiTAC® T-Cell Engager Program With Cell Line Development Partnership
VERAXA Biotech has initiated cell line development for its lead BiTAC T-cell engager program, partnering with ATUM to advance the candidate toward cli...
Quantum BioPharma Ltd. Advances Diversified Platform Targeting Neurodegenerative and Metabolic Disorders
Quantum BioPharma is progressing a multi-platform strategy combining clinical-stage therapeutics, consumer wellness products, and strategic investment...
Ocumetics Advances First-in-Human Study with Positive Six-Month Clinical Results and Next-Generation Lens
Ocumetics Technology Corp. reports positive six-month clinical data from its First-in-Human study, supporting progression to Group Two surgeries, whil...
Oncotelic Therapeutics Launches AI-Powered GMP Manufacturing Platform to Address Biotech Bottleneck
Oncotelic Therapeutics has introduced an AI-driven GMP manufacturing services platform aimed at helping emerging biotechs overcome the costly and comp...
Greenland Mines Advances Skaergaard Project with Expert Workshop
Greenland Mines Ltd held a three-day development planning workshop with international specialists to advance its Skaergaard precious and critical meta...
VERAXA Biotech Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership
VERAXA Biotech has initiated cell line development for its lead BiTAC(R) T-cell engager program by partnering with ATUM, marking a key step toward IND...
NanoViricides Receives Analyst Initiation with Outperform Rating and $6 Price Target
NanoViricides, a clinical-stage antiviral developer, has been initiated with an Outperform rating and $6 price target by Noble Capital Markets, highli...